Literature DB >> 8440793

Polymicrobial bacteremia in critically ill patients.

J Rello1, E Quintana, B Mirelis, M Gurguí, A Net, G Prats.   

Abstract

OBJECTIVE: To characterize the epidemiology of polymicrobial bacteremia (PMB) among critically ill patients.
DESIGN: Prospective clinical study.
SETTING: University medical center. PATIENTS: All patients with positive blood cultures in a medical-surgical ICU. MEASUREMENTS: PMB represents 8.4% of all true bacteremia in our ICU. Most of these patients were postoperative but none had malignancies or significant immunodepression. Over three-quarters of the episodes were nosocomial. No significant differences in factors associated with PMB were found when they were compared with a cohort of 154 monomicrobial episodes. Enterobacteriaceae were the most common organisms. Intravascular devices (42.8%) were the most common source of PMB, followed by intra-abdominal origin (21.4%). The overall mortality was 7.1%, a lower rate than has previously been described.
CONCLUSIONS: We suggest catheter replacement in patients who develop PMB and improving techniques of catheter maintenance in order to reduce its incidence.

Entities:  

Mesh:

Year:  1993        PMID: 8440793     DOI: 10.1007/bf01709273

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  24 in total

Review 1.  Risk factors for nosocomial infection in intensive care. 'Devices vs nature' and goals for the next decade.

Authors:  D G Maki
Journal:  Arch Intern Med       Date:  1989-01

2.  Diagnosis of central venous catheter-related sepsis. Critical level of quantitative tip cultures.

Authors:  C Brun-Buisson; F Abrouk; P Legrand; Y Huet; S Larabi; M Rapin
Journal:  Arch Intern Med       Date:  1987-05

3.  Septicemia from biliary tract infection.

Authors:  Y Siegman-Igra; D Schwartz; N Konforti; C Perluk; R R Rozin
Journal:  Arch Surg       Date:  1988-03

4.  Polymicrobial bloodstream infections related to prolonged vascular catheterization.

Authors:  S Ponce de Leon; S Critchley; R P Wenzel
Journal:  Crit Care Med       Date:  1984-10       Impact factor: 7.598

Review 5.  Polymicrobial bacteremia in the late 1980s: predictors of outcome and review of the literature.

Authors:  G S Cooper; D S Havlir; D M Shlaes; R A Salata
Journal:  Medicine (Baltimore)       Date:  1990-03       Impact factor: 1.889

Review 6.  Gram-negative bacteremia. IV. Re-evaluation of clinical features and treatment in 612 patients.

Authors:  B E Kreger; D E Craven; W R McCabe
Journal:  Am J Med       Date:  1980-03       Impact factor: 4.965

7.  Acute cholangitis.

Authors:  J H Boey; L W Way
Journal:  Ann Surg       Date:  1980-03       Impact factor: 12.969

8.  Comparative culture methods on 101 intravenous catheters. Routine, semiquantitative, and blood cultures.

Authors:  M A Moyer; L D Edwards; L Farley
Journal:  Arch Intern Med       Date:  1983-01

Review 9.  Polymicrobial bacteremia: clinical and microbiologic patterns.

Authors:  A G Reuben; D M Musher; R J Hamill; I Broucke
Journal:  Rev Infect Dis       Date:  1989 Mar-Apr

10.  Quantitative culture of intravenous catheters and other intravascular inserts.

Authors:  D J Cleri; M L Corrado; S J Seligman
Journal:  J Infect Dis       Date:  1980-06       Impact factor: 5.226

View more
  10 in total

1.  Impact of nosocomial polymicrobial bloodstream infections on the outcome in critically ill patients.

Authors:  S Sancho; A Artero; R Zaragoza; J J Camarena; R González; J M Nogueira
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-12-14       Impact factor: 3.267

2.  Case mortality in polymicrobial bloodstream infections.

Authors:  F E McKenzie
Journal:  J Clin Epidemiol       Date:  2006-05-02       Impact factor: 6.437

3.  Early and late onset bacteremia have different risk factors in trauma patients.

Authors:  M Antonelli; M L Moro; R R D'Errico; G Conti; M Bufi; A Gasparetto
Journal:  Intensive Care Med       Date:  1996-08       Impact factor: 17.440

Review 4.  A 'culture' shift: Application of molecular techniques for diagnosing polymicrobial infections.

Authors:  Yi Zhang; Anne Hu; Nadya Andini; Samuel Yang
Journal:  Biotechnol Adv       Date:  2019-02-20       Impact factor: 14.227

5.  Nosocomial bacteremia in a medical-surgical intensive care unit: epidemiologic characteristics and factors influencing mortality in 111 episodes.

Authors:  J Rello; M Ricart; B Mirelis; E Quintana; M Gurgui; A Net; G Prats
Journal:  Intensive Care Med       Date:  1994       Impact factor: 17.440

6.  Application of a microsphere-based array for rapid identification of Acinetobacter spp. with distinct antimicrobial susceptibilities.

Authors:  Yu-Chi Lin; Wang-Huei Sheng; Shan-Chwen Chang; Jann-Tay Wang; Yee-Chun Chen; Ruei-Jiuan Wu; Ko-Chiang Hsia; Shu-Ying Li
Journal:  J Clin Microbiol       Date:  2007-11-26       Impact factor: 5.948

7.  An efficient strategy for broad-range detection of low abundance bacteria without DNA decontamination of PCR reagents.

Authors:  Shy-Shin Chang; Hsung-Ling Hsu; Ju-Chien Cheng; Ching-Ping Tseng
Journal:  PLoS One       Date:  2011-05-26       Impact factor: 3.240

8.  Polymicrobial bloodstream infection in neonates: microbiology, clinical characteristics, and risk factors.

Authors:  Ming-Horng Tsai; Shih-Ming Chu; Jen-Fu Hsu; Reyin Lien; Hsuan-Rong Huang; Ming-Chou Chiang; Ren-Huei Fu; Chiang-Wen Lee; Yhu-Chering Huang
Journal:  PLoS One       Date:  2014-01-14       Impact factor: 3.240

9.  Risk Factors of Bacteremia following Multiple Traumas.

Authors:  Hak-Jae Lee; Eol Choi; Nak-Joon Choi; Hyun-Woo Sun; Jae-Suk Lee; Jeong-Woo Lee; Tae-Yoon Kim; Yoon-Joong Jung; Suk-Kyung Hong
Journal:  Emerg Med Int       Date:  2020-04-06       Impact factor: 1.112

10.  Clinical characteristics and risk factors of polymicrobial Staphylococcus aureus bloodstream infections.

Authors:  Cheng Zheng; Shufang Zhang; Qingqing Chen; Li Zhong; Tiancha Huang; Xijiang Zhang; Kai Zhang; Hongwei Zhou; Jiachang Cai; Linlin Du; Changming Wang; Wei Cui; Gensheng Zhang
Journal:  Antimicrob Resist Infect Control       Date:  2020-05-27       Impact factor: 4.887

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.